- Home
- Articles
- us virgislands
- antigen design
Antigen Design Articles & Analysis
15 articles found
Challenges in Peptide Vaccine DevelopmentDespite the theoretical advantages of peptide-based vaccine platforms, many technical difficulties remain in practical development. Complexity of Antigen Design in VaccinesSuccessful peptide vaccine development requires thorough analysis of the immune mechanisms of diseases and the relationship between pathogen structure ...
However, with advancements in biotechnology and biochemistry, the design of antibody-based therapies has undergone a paradigm shift. Techniques such as recombinant DNA technology and hybridoma technology have allowed scientists to create monoclonal antibodies, which are identical copies of a specific antibody that targets a particular antigen. Innovations in ...
Alfa Cytology's immune checkpoint inhibitor services are specifically designed to address these challenges by offering customized, high-quality solutions that are tailored to the unique immunological characteristics of different cancers. Alfa Cytology’s expertise in immune checkpoint inhibitor development services includes small molecule inhibitors, antibodies, and vaccines. ...
In biomedical research, antibodies are a powerful tool used in the detection and quantification of target antigens. However, a comprehensive understanding of the antibody requires knowledge of its amino acid sequence, which can be achieved through antibody sequencing.Antibody sequencing is a nucleic acid sequencing process that determines the nucleotide sequence of the gene ...
They have the advantages of small size, high stability, and good penetration, and therefore have a wide range of application prospects in the fields of clinical treatment, diagnostic reagent development, etc.Characteristics of NanobodiesThe size of nanobodies usually ranges between 10-15kDa, which is only 1/10 of the size of regular antibodies. Their unique antigen-binding ...
This epitope might show high similarity or significant differences in sequence across different species.From a purely practical perspective, compared to other forms of antigens, the synthesis of peptides also has the advantages of being simple, fast, and inexpensive.The Key to Designing the Right PeptidesPeptides have long been the preferred ...
Linkers play a crucial role in the design of conjugated drugs, as they determine the stability, release kinetics, and overall efficacy of the conjugate. BOC Sciences offers a variety of linkers, including cleavable linkers, non-cleavable linkers, and pH-sensitive linkers, to accommodate different drug payloads and target antigens. These linkers are ...
Nanobodies are the smallest functional single-domain antibodies known to be able to stably bind to antigens, and have unique structural and functional advantages. The molecular weight of nanobodies is only 12-15 kDa, which retains the antigen binding ability of traditional antibodies. ...
Furthermore, the KineTAC platform only requires the design of the antigen-binding arm for the target protein, as natural cytokines can recruit the relevant degradation receptors. To validate the KineTAC platform design concept, the authors developed KineTAC bispecific antibodies targeting different target proteins (PD-L1, HER2, PD-1, EGFR, ...
Antibody Backbone: The Starting Point for ADC Design l Selection of antigen specificity Since the mechanism of ADCs begins with the binding of target cells, the antibody should have high specificity for the target antigen. Ideally, the antigen should be overexpressed on the surface of tumor cells and not expressed (or very low) ...
Structurally, an ADC consists of monoclonal antibodies (Antibody) that target specific antigens on tumor surfaces, cytotoxic drugs (drugs) that kill tumor cells, and linkers (Conjugate/ linkers) that conjugate cytotoxic drugs to antibodies. ...
Why target GPCRs with antibodies? The G Protein-coupled receptor (GPCR) superfamily represents the largest and single most important family of human drug targets. GPCRs play a central role in a plethora of biological processes and are linked to a wide range of therapeutic areas including cancer, diabetes, inflammation, cardiovascular diseases, and chronic pain. Expressed in every type of cell in ...
Antibodies with catalytic activity can be obtained by using pre-designed antigens (haptens) according to the preparation procedures of general monoclonal antibodies. ...
Using the power of large data and advanced computational methods, researchers can identify peptides on the surface of tumor cells and can target "peptide-centric" chimeric antigen receptors (PC-CARs): a new design of T cells that stimulates the immune response to eliminate tumors. ...
The introduction rule uses genetic engineering and protein engineering to introduce a catalytic gene into the antigen binding site of a specific antibody to obtain a catalytic function. The copy method is mainly designed according to the antigen-antibody complementarity during the antibody production process. ...